Recent developments in the treatment of aggressive non-Hodgkin lymphoma
- 31 January 2009
- journal article
- review article
- Published by Elsevier BV in Blood Reviews
- Vol. 23 (1), 11-23
- https://doi.org/10.1016/j.blre.2008.05.002
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia studySupportive Care in Cancer, 2008
- Estimates of the cancer incidence and mortality in Europe in 2006Annals of Oncology, 2007
- EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumoursEuropean Journal of Cancer, 2006
- 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice GuidelineJournal of Clinical Oncology, 2006
- Population-based Assessment of Hospitalizations for Neutropenia from Chemotherapy in Older Adults with Non-Hodgkin’s Lymphoma (United States)Cancer Causes & Control, 2006
- Pegfilgrastim to support CHOP-14 in elderly patients with non-Hodgkin's lymphomaLeukemia & Lymphoma, 2006
- Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'AdulteJournal of Clinical Oncology, 2005
- ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed large cell non-Hodgkin's lymphomaAnnals of Oncology, 2005
- Changing trends in the incidence of non-Hodgkin's lymphoma in EuropeAnnals of Oncology, 1997
- Survival of diffuse large cell lymphoma. A multivariate analysis including dose intensity variablesCancer, 1990